SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)

Italy flag Italy · Delayed Price · Currency is EUR
15.38
-0.86 (-5.30%)
At close: Dec 9, 2025
-39.45%
Market Cap2.28B
Revenue (ttm)986.21M
Net Income (ttm)146.45M
Shares Outn/a
EPS (ttm)0.97
PE Ratio15.57
Forward PE15.59
Dividendn/a
Ex-Dividend Daten/a
Volume500
Average Volume227
Open15.80
Previous Close16.24
Day's Range15.80 - 15.80
52-Week Range15.38 - 30.40
Betan/a
RSI28.05
Earnings DateDec 11, 2025

About BIT:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. It offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT... [Read more]

Industry Glass Containers
Founded 1884
Employees 4,690
Stock Exchange Borsa Italiana
Ticker Symbol 1SXP
Full Company Profile

Financial Performance

In 2025, BIT:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements

News

There is no news available yet.